名稱 | bTMB-P1 (22.91) Reference Standard |
型號(hào) | CBP80001-10 |
報(bào)價(jià) | ![]() |
特點(diǎn) | bTMB-P1 (22.91) Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- IL36靶點(diǎn)藥物細(xì)胞篩選模型藥
- 黃金賽道——CDH17靶點(diǎn)
- 【新品發(fā)布】MRD標(biāo)準(zhǔn)品_40+位點(diǎn)panel標(biāo)準(zhǔn)品
- ATCC細(xì)胞的細(xì)胞破碎
- ERBB2基因檢測標(biāo)準(zhǔn)品
- 【基因編輯產(chǎn)品新品上市】MET Ex14 skipping新添成員
- IL2細(xì)胞篩選模型
- 【靶點(diǎn)模型+診斷質(zhì)控】FLT3-ITD的藥物開發(fā)和診斷
- PLoS ONE:科學(xué)家發(fā)現(xiàn)癌癥轉(zhuǎn)移的新線索
- HRD檢測之我見---科佰生物
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 其他類別 > CBP80001-10bTMB-P1 (22.91) Reference Standard

- 詳細(xì)內(nèi)容
CBP80001-10 | |||||||||||||||||||||||||||||||||||||||||||||||
I. Background | |||||||||||||||||||||||||||||||||||||||||||||||
Tumor mutational burden (TMB) shows great promise as a biomarker for immuno-oncology (I-O) therapy response, but progress is hindered by the lack of a standardized TMB measurement by targeted NGS panels, and an absence of TMB reference materials.
| |||||||||||||||||||||||||||||||||||||||||||||||